Initially, to validate METTL3 as a critical target for AML cell viability, we generated METTL3 knockdown MOLM13 cell lines (shMETTL3 #1 and shMETTL3 #2) using a shRNA vector system. Here, METTL3 is linked to acute myeloid leukemia.